| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1996;28:758-764.)
© 1996 American Heart Association, Inc.
Articles |
Distinct Factors in Plasma of Preeclamptic Women Increase Endothelial Nitric Oxide or Prostacyclin
the Magee-Womens Research Institute and Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh (Pa).
Correspondence to Sandra T. Davidge, Perinatal Research Institute, 220 HMRC, University of Alberta, Edmonton, AB, Canada, T6G 2S2. E-mail sdavidge@gpu.srv.ualberta.ca.
The pathogenesis of preeclampsia is proposed to be due to uncharacterized circulating factors that activate endothelial cells. Support for this hypothesis is provided by in vitro activation of endothelial cells by plasma from preeclamptic women, eg, increased nitric oxide and prostacyclin generation. We performed molecular sizing, lipid extraction, and lipoprotein fractionation of plasma from normal pregnant and preeclamptic women and determined the ability of these plasma fractions to increase nitric oxide or prostacyclin generation by endothelial cells. Fractions from plasma of preeclamptic women were consistently more active than fractions from normal pregnant women, although characterization was qualitatively similar. The factors stimulating nitric oxide and prostacyclin were different. The factor (or factors) stimulating nitric oxide generation was extractable by charcoal and present in lipid extracts and lipoprotein isolates with a molecular weight greater that 1.5 million daltons, which is characteristic of a lipoprotein or lipoprotein aggregate. By contrast, activity to stimulate prostacyclin persisted after charcoal stripping or lipoprotein removal, partitioned to the aqueous fraction, and had a molecular weight of approximately 50 000 D. Two distinct factors in the blood of preeclamptic women alter endothelial function in vitro. This information should guide the search for circulating factors contributing to the pathophysiology of preeclampsia.
Key Words: preeclampsia • endothelium • nitric oxide • prostaglandin • lipids • lipoproteins • pregnancy
This article has been cited by other articles:
 |
|
 |
|
  J. Martinez-Orgado, R. Gonzalez, M. J. Alonso, and M. Salaices Impairment of Fetal Endothelium-Dependent Relaxation in a Rat Model of Preeclampsia by Chronic Nitric Oxide Synthase Inhibition Reproductive Sciences, February 1, 2004; 11(2): 82 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 R. A. Khalil and J. P. Granger Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R29 - R45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rowe, S. Campbell, and E. D. M. Gallery Plasma From Preeclamptic Women Stimulates Decidual Endothelial Cell Growth and Prostacyclin but Not Nitric Oxide Production: Close Correlation of Prostacyclin and Thromboxane Production Reproductive Sciences, January 1, 2001; 8(1): 32 - 38. [Abstract] [PDF]
|
|
|
|
 |
|
 J. GREEN, S. ASSADY, F. NAKHOUL, T. BICK, P. JAKOBI, and Z. ABASSI Differential Effects of Sera from Normotensive and Hypertensive Pregnant Women on Ca2+ Metabolism in Normal Vasular Smooth Muscle Cells J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1188 - 1198. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. M. Roberts Angiotensin-1 Receptor Autoantibodies : A Role in the Pathogenesis of Preeclampsia? Circulation, May 23, 2000; 101(20): 2335 - 2337. [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Hubel Oxidative Stress in the Pathogenesis of Preeclampsia Experimental Biology and Medicine, December 1, 1999; 222(3): 222 - 235. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Wellings, J. C. Brockelsby, and P. N. Baker Activation of Endothelial Cells by Plasma From Women With Preeclampsia: Differential Effects on Four Endothelial Cell Types Reproductive Sciences, January 1, 1998; 5(1): 31 - 37. [Abstract] [PDF]
|
|